We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$13.7B
Cap. Flow %
-12.39%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Consumer Discretionary 9.92%
3 Healthcare 7.34%
4 Financials 7.06%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCICW
3401
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
$1.07M ﹤0.01%
853,875
FRPT icon
3402
Freshpet
FRPT
$3.6B
$1.07M ﹤0.01%
7,469
-71,216
-91% -$10.2M
LZB icon
3403
La-Z-Boy
LZB
$1.3B
$1.06M ﹤0.01%
33,059
+20,970
+173% +$723K
RDS.A
3404
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.06M ﹤0.01%
23,900
+4,400
+23% +$178K
IT icon
3405
PUT
Gartner
IT
$12.2B
$1.06M ﹤0.01%
+3,500
New +$1.01M
CNC icon
3406
Centene
CNC
$32.3B
$1.06M ﹤0.01%
17,002
-46,314
-73% -$3.09M
DSX icon
3407
Diana Shipping
DSX
$332M
$1.06M ﹤0.01%
264,277
-15,081
-5% -$49.9K
PDYN icon
3408
Palladyne AI
PDYN
$296M
$1.06M ﹤0.01%
22,780
FATE icon
3409
Fate Therapeutics
FATE
$308M
$1.06M ﹤0.01%
17,821
-65,727
-79% -$5.16M
MVIS icon
3410
Microvision
MVIS
$56.6M
$1.06M ﹤0.01%
6,370
-134,610
-95% -$28.1M
WGSWW
3411
DELISTED
GeneDx Holdings Warrant
WGSWW
$1.06M ﹤0.01%
498,333
GPX
3412
DELISTED
GP Strategies Corp.
GPX
$1.05M ﹤0.01%
50,863
-4,482
-8% -$88.9K
NBTB icon
3413
NBT Bancorp
NBTB
$2.68B
$1.05M ﹤0.01%
29,110
+22,989
+376% +$807K
GLUE icon
3414
Monte Rosa Therapeutics
GLUE
$1.23B
$1.05M ﹤0.01%
+47,124
New +$1.35M
SP
3415
DELISTED
SP Plus Corporation
SP
$1.05M ﹤0.01%
34,241
+5,562
+19% +$173K
DLCA
3416
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$1.05M ﹤0.01%
+107,651
New +$1.04M
SAVE
3417
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$1.05M ﹤0.01%
40,400
-10,800
-21% -$283K
AKAM icon
3418
PUT
Akamai
AKAM
$15.5B
$1.05M ﹤0.01%
10,000
GES
3419
CALL
DELISTED
Guess Inc
GES
$1.05M ﹤0.01%
49,800
UVSP icon
3420
Univest Financial
UVSP
$1.15B
$1.05M ﹤0.01%
38,178
-6,276
-14% -$168K
HONE
3421
DELISTED
HarborOne Bancorp
HONE
$1.04M ﹤0.01%
74,450
-23,274
-24% -$322K
PLXS icon
3422
Plexus
PLXS
$6.52B
$1.04M ﹤0.01%
11,691
+4,887
+72% +$435K
CSAN icon
3423
Cosan
CSAN
$2.78B
$1.04M ﹤0.01%
62,319
+29,931
+92% +$549K
GNLN icon
3424
Greenlane Holdings
GNLN
$2.08M
0
EXTN
3425
DELISTED
Exterran Corporation
EXTN
$1.04M ﹤0.01%
234,747
-125,643
-35% -$533K

Similar funds

David Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, David Shaw opened a new position in Sea Limited worth $206M.

  • David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • David Shaw opened 915 new positions and closed 695 in Q3 2021.
  • David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.